These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3115279)

  • 1. Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine brucellosis.
    Limet J; Plommet AM; Dubray G; Plommet M
    Ann Inst Pasteur Immunol; 1987; 138(3):417-24. PubMed ID: 3115279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella.
    Limet JN; Bosseray N; Garin-Bastuji B; Dubray G; Plommet M
    J Med Microbiol; 1989 Sep; 30(1):37-43. PubMed ID: 2506351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice.
    Winter AJ; Duncan JR; Santisteban CG; Douglas JT; Adams LG
    Infect Immun; 1989 Nov; 57(11):3438-44. PubMed ID: 2509362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune serum-mediated effects on brucellosis evolution in mice.
    Plommet M; Plommet AM
    Infect Immun; 1983 Jul; 41(1):97-105. PubMed ID: 6408007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.
    Bhattacharjee AK; Van de Verg L; Izadjoo MJ; Yuan L; Hadfield TL; Zollinger WD; Hoover DL
    Infect Immun; 2002 Jul; 70(7):3324-9. PubMed ID: 12065469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella.
    Jacques I; Cloeckaert A; Limet JN; Dubray G
    J Med Microbiol; 1992 Aug; 37(2):100-3. PubMed ID: 1378499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.
    Araya LN; Elzer PH; Rowe GE; Enright FM; Winter AJ
    J Immunol; 1989 Nov; 143(10):3330-7. PubMed ID: 2509555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and suppression of the humoral immune response in mice mediated by a monoclonal antibody against the M epitope of Brucella.
    Vizcaíno N; Fernández-Lago L
    FEMS Immunol Med Microbiol; 1994 Feb; 8(2):133-9. PubMed ID: 7513589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice.
    Fernández-Lago L; Monte M; Chordi A
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):109-14. PubMed ID: 8880135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen.
    Phillips M; Deyoe BL; Canning PC
    Am J Vet Res; 1989 Dec; 50(12):2158-61. PubMed ID: 2481994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BALB/c mice infected with Brucella abortus express protracted polyclonal responses of both IgG2a and IgG3 isotypes.
    Elzer PH; Jacobson RH; Nielsen KH; Douglas JT; Winter AJ
    Immunol Lett; 1994 Oct; 42(3):145-50. PubMed ID: 7890314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective activity to murine experimental brucellosis conferred by monoclonal antibody ISS/32 anti-B. abortus.
    Adone R; Ciuchini F; Pistoia C; Marcon G; Piccininno G
    Zentralbl Veterinarmed B; 1991 Jul; 38(5):397-400. PubMed ID: 1718101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine and serum-mediated protection against brucella infection of mouse placenta.
    Bosseray N
    Br J Exp Pathol; 1983 Dec; 64(6):617-25. PubMed ID: 6419766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308.
    Pugh GW; Phillips M; Tabatabai LB; McDonald TJ
    Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115.
    Cloeckaert A; Zygmunt MS; Dubray G; Limet JN
    J Gen Microbiol; 1993 Jul; 139(7):1551-6. PubMed ID: 7690392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum.
    Pardon P
    Ann Immunol (Paris); 1977; 128(6):1025-37. PubMed ID: 413471
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenic properties of Brucella melitensis cell-wall fractions in BALB/c mice.
    Cloeckaert A; Jacques I; Limet JN; Dubray G
    J Med Microbiol; 1995 Mar; 42(3):200-8. PubMed ID: 7884802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.